Alpha Metallurgical Resources (AMR) had the highest return in September 2016 by a mid-cap US stock, returning 81.5%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Alpha Metallurgical Resources (AMR) | September 2016 | 81.52% |
Protagonist Therapeutics (PTGX) | September 2016 | 75.94% |
PTC Therapeutics (PTCT) | September 2016 | 70.85% |
Bank of NT Butterfield & Son (NTB) | September 2016 | 66.69% |
Impinj (PI) | September 2016 | 41.1% |
Travere Therapeutics (TVTX) | September 2016 | 39.09% |
Veracyte (VCYT) | September 2016 | 35.17% |
Wave Life Sciences (WVE) | September 2016 | 34.95% |
CleanSpark (CLSK) | September 2016 | 32.73% |
Applied Opt (AAOI) | September 2016 | 31.11% |
Pampa Energia SA ADR (PAM) | September 2016 | 28.67% |
ADMA Biologics (ADMA) | September 2016 | 28.37% |
AAR (AIR) | September 2016 | 27.32% |
Glaukos (GKOS) | September 2016 | 26.22% |
Silvercorp Metals (SVM) | September 2016 | 24.95% |
Methanex (MEOH) | September 2016 | 24.18% |
Eldorado Gold (EGO) | September 2016 | 23.97% |
Argan (AGX) | September 2016 | 23.8% |
AXT (AXTI) | September 2016 | 22.99% |
Halozyme Therapeutics (HALO) | September 2016 | 22.64% |
Chord Energy (CHRD) | September 2016 | 22.28% |
Celldex Therapeutics (CLDX) | September 2016 | 22.05% |
Corcept Therapeutics (CORT) | September 2016 | 21.95% |
TG Therapeutics (TGTX) | September 2016 | 21.89% |
MakeMyTrip (MMYT) | September 2016 | 20.84% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
